HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John A. Hawkins Edwin C. McGough Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hawkins, J. A. Articles by Shaddy, R. E. Search for Related Content PubMed PubMed Citation Articles by Hawkins, J. A. Articles by Shaddy, R. E.

J Thorac Cardiovasc Surg 2000;119:324-330
© 2000 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

CLASS I AND CLASS II ANTI-HLA ANTIBODIES AFTER IMPLANTATION OF CRYOPRESERVED ALLOGRAFT MATERIAL IN PEDIATRIC PATIENTS

From the Departments of Surgery, Pathology, and Pediatrics, Primary Children’s Medical Center and the University of Utah, Salt Lake City, Utah.

Address for reprints: John A. Hawkins, MD, Pediatric Cardiothoracic Surgery, Primary Children’s Medical Center, 100 North Medical Dr, Salt Lake City, UT 84113 (E-mail: jhawkins{at}med.utah.edu) .

Objectives: Very little is known regarding the immune response to cryopreserved allograft valves and patch material used in the surgical repair of congenital heart defects.
Methods: We prospectively measured the frequency of panel reactive antibodies directed against HLA class I (HLA-A, B, and C) and class II (HLA-DR/DQ) alloantigens in 24 children receiving cryopreserved allografts. We compared them with results in 11 previously reported control patients. Sixteen of the study patients underwent placement of a valved conduit (11 pulmonic, 5 aortic) between the right ventricle and pulmonary arteries, 6 underwent patch angioplasty of stenotic vessels with cryopreserved pulmonary artery, and 2 underwent placement of a pulmonary monocusp patch. Study patients had panel reactive antibodies measured before, 1 month, 3 months, and 1 year after the operation.
Results: With allograft implantation, panel reactive antibodies increased from 1.9% ± 5% before the operation to 62% ± 33% at 31 ± 8 days after the operation, 92% ± 15% at 3.3 ± 0.6 months after the operation, and 85% ± 18% at 1.1 ± 0.2 years after the operation. The control group showed no change in panel reactive antibodies, with a level of 1.6% ± 1% before the operation, 3.2% ± 1% 28 ± 5 days after the operation, and 1.7% ± 1% 2.7 ± 0.3 months after the operation. Class II antibodies (anti-HLA-DR/DQ) rose to 49% ± 35% at 30 ± 8 days and 70% ± 26% at 3.3 ± 0.6 months after the operation.
Conclusions: Cryopreserved allograft material induces a marked response that involves both class I and class II anti-HLA antibodies within 3 months after operation in children. This alloantibody response may represent a form of "rejection," may have implications for those who require subsequent cardiac transplantation, and may play a role in early allograft failure.

This article has been cited by other articles:

				G. Furlanetto, C. H Passerino, R. Siegel, D. T Chueng, S. Levitsky, and I. S J Casagrande Biointegration and Growth of Porcine Valved Pulmonary Conduits in a Sheep Model Asian Cardiovasc Thorac Ann, August 1, 2009; 17(4): 350 - 356. [Abstract] [Full Text] [PDF]

				B. Feingold, P. D. Wearden, V. O. Morell, D. Galvis, and C. Galambos Expression of A and B Blood Group Antigens on Cryopreserved Homografts Ann. Thorac. Surg., January 1, 2009; 87(1): 211 - 214. [Abstract] [Full Text] [PDF]

				M. L. Jacobs Invited Commentary Ann. Thorac. Surg., January 1, 2009; 87(1): 214 - 215. [Full Text] [PDF]

				A. Gomez-Caro, E. Martinez, A. Rodriguez, D. Sanchez, J. Martorell, J. M. Gimferrer, A. Haverich, W. Harringer, J. L. Pomar, and P. Macchiarini Cryopreserved Arterial Allograft Reconstruction After Excision of Thoracic Malignancies Ann. Thorac. Surg., December 1, 2008; 86(6): 1753 - 1761. [Abstract] [Full Text] [PDF]

				J. Simmonds, M. Burch, H. Dawkins, and V. Tsang Heart transplantation after congenital heart surgery: improving results and future goals. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 313 - 317. [Abstract] [Full Text] [PDF]

				E. Troost, B. Meyns, W. Daenen, F. Van de Werf, M. Gewillig, K. Van Deyk, P. Moons, and W. Budts Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration Eur. Heart J., October 2, 2007; 28(20): 2503 - 2509. [Abstract] [Full Text] [PDF]

				S. R. Meyer, D. B. Ross, K. Forbes, L. E. Hawkins, A. M. Halpin, S. N. Nahirniak, J. M. Rutledge, I. M. Rebeyka, and P. M. Campbell Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1517 - 1523. [Abstract] [Full Text] [PDF]

				S. Cebotari, A. Lichtenberg, I. Tudorache, A. Hilfiker, H. Mertsching, R. Leyh, T. Breymann, K. Kallenbach, L. Maniuc, A. Batrinac, et al. Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells Circulation, July 4, 2006; 114(1_suppl): I-132 - I-137. [Abstract] [Full Text] [PDF]

				S. R. Meyer, J. Nagendran, L. S. Desai, G. R. Rayat, T. A. Churchill, C. C. Anderson, R. V. Rajotte, J. R.T. Lakey, and D. B. Ross Decellularization reduces the immune response to aortic valve allografts in the rat J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 469 - 476. [Abstract] [Full Text] [PDF]

				S. R. Meyer, P. M. Campbell, J. M. Rutledge, A. M. Halpin, L. E. Hawkins, J. R.T. Lakey, I. M. Rebeyka, and D. B. Ross Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 554 - 560. [Abstract] [Full Text] [PDF]

				F. D. Affonso da Costa, P. M. Dohmen, D. Duarte, C. von Glenn, S. V. Lopes, H. H. Filho, M. B. Affonso da Costa, and W. Konertz Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 572 - 578. [Abstract] [Full Text] [PDF]

				D. K. Hooper, J. A. Hawkins, T. C. Fuller, T. Profaizer, and R. E. Shaddy Panel-Reactive Antibodies Late After Allograft Implantation in Children Ann. Thorac. Surg., February 1, 2005; 79(2): 641 - 644. [Abstract] [Full Text] [PDF]

				A. Ketchedjian, P. Kreuger, H. Lukoff, E. Robinson, A. Linthurst-Jones, K. Crouch, L. Wolfinbarger, and R. Hopkins Ovine panel reactive antibody assay of HLA responsivity to allograft bioengineered vascular scaffolds J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 159 - 166. [Abstract] [Full Text] [PDF]

				R. E. Shaddy, T. C. Fuller, J. B. Anderson, L. M. Lambert, M. K. Brinkman, T. Profaizer, and J. A. Hawkins Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation Ann. Thorac. Surg., May 1, 2004; 77(5): 1734 - 1739. [Abstract] [Full Text] [PDF]

				J. T. Christenson, D. Vala, J. Sierra, M. Beghetti, and A. Kalangos Blood group incompatibility and accelerated homograft fibrocalcifications J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 242 - 250. [Abstract] [Full Text] [PDF]

				P. G. Hogan and M. F. O'Brien Improving the allograft valve: does the immune response matter? J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1251 - 1253. [Full Text] [PDF]

				W. Wells, M. Malas, C. J. Baker, S. M. Quardt, and M. L. Barr Depopulated vena caval homograft: a new venous conduit J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 498 - 503. [Abstract] [Full Text] [PDF]

				R. J. F. Baskett, M. A. Nanton, A. E. Warren, and D. B. Ross Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 232 - 238. [Abstract] [Full Text] [PDF]

				J. A. Hawkins, N. D. Hillman, L. M. Lambert, J. Jones, G. B. Di Russo, T. Profaizer, T. C. Fuller, L. L. Minich, R. V. Williams, and R. E. Shaddy Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 247 - 252. [Abstract] [Full Text] [PDF]

				D. R. Clarke Presidential address: Value, viability, and valves J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6. [Full Text] [PDF]

				W. J. Wells, H. Arroyo Jr, R. M. Bremner, J. Wood, and V. A. Starnes Homograft conduit failure in infants is not due to somatic outgrowth J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 88 - 96. [Abstract] [Full Text] [PDF]

				R. C. Elkins, P. E. Dawson, S. Goldstein, S. P. Walsh, and K. S. Black Decellularized human valve allografts Ann. Thorac. Surg., May 1, 2001; 71 (2007): S428 - S432. [Abstract] [Full Text] [PDF]